Ciglitazone, a PPARgamma agonist, ameliorates diabetic nephropathy in part through homocysteine clearance (Q36977008)

From Wikidata
Jump to navigation Jump to search
scientific article published on 09 September 2008
edit
Language Label Description Also known as
English
Ciglitazone, a PPARgamma agonist, ameliorates diabetic nephropathy in part through homocysteine clearance
scientific article published on 09 September 2008

    Statements

    Ciglitazone, a PPARgamma agonist, ameliorates diabetic nephropathy in part through homocysteine clearance (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit